BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Glantzounis GK, Tokidis E, Basourakos SP, Ntzani EE, Lianos GD, Pentheroudakis G. The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review. Eur J Surg Oncol. 2017;43:32-41. [PMID: 27283892 DOI: 10.1016/j.ejso.2016.05.026] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 8.2] [Reference Citation Analysis]
Number Citing Articles
1 Cholangiocarcinoma Working Group. Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment. Dig Liver Dis 2020;52:1430-42. [PMID: 32952071 DOI: 10.1016/j.dld.2020.08.030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
2 Olthof PB, Aldrighetti L, Alikhanov R, Cescon M, Groot Koerkamp B, Jarnagin WR, Nadalin S, Pratschke J, Schmelze M, Sparrelid E, Lang H, Guglielmi A, van Gulik TM; Perihilar Cholangiocarcinoma Collaboration Group. Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma. Ann Surg Oncol 2020;27:2311-8. [PMID: 32103419 DOI: 10.1245/s10434-020-08258-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
3 Strohmaier A, Wagner KC, Reese T, Fard-Aghaie M, Makridis G, Rittberg YV, Horling K, Oldhafer KJ. Extended liver resection including hypertrophy concept with portal venous embolisation for giant haemangioma. Too much surgery? Ann Hepatobiliary Pancreat Surg 2020;24:357-61. [PMID: 32843605 DOI: 10.14701/ahbps.2020.24.3.357] [Reference Citation Analysis]
4 Feng JW, Yang XH, Wu BQ, Jiang Y, Qu Z. Progress in diagnosis and surgical treatment of perihilar cholangiocarcinoma. Gastroenterol Hepatol 2019;42:271-9. [PMID: 30583874 DOI: 10.1016/j.gastrohep.2018.11.003] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Cillo U, Fondevila C, Donadon M, Gringeri E, Mocchegiani F, Schlitt HJ, Ijzermans JNM, Vivarelli M, Zieniewicz K, Olde Damink SWM, Groot Koerkamp B. Surgery for cholangiocarcinoma. Liver Int 2019;39 Suppl 1:143-55. [PMID: 30843343 DOI: 10.1111/liv.14089] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 20.0] [Reference Citation Analysis]
6 Bekki Y, Marti J, Toshima T, Lewis S, Kamath A, Argiriadi P, Simpson W, Facciuto L, Patel RS, Gunasekaran G, Kim E, Schiano TD, Facciuto ME. A comparative study of portal vein embolization versus radiation lobectomy with Yttrium-90 micropheres in preparation for liver resection for initially unresectable hepatocellular carcinoma. Surgery 2021;169:1044-51. [PMID: 33648768 DOI: 10.1016/j.surg.2020.12.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Ouyang G, Liu J, Wang P, Ren Y, Yi P, Zhou Q, Chen J, Xiang B, Zhang Y, Zhang Z, Li L. Multiple factors affect the regeneration of liver. Rev Assoc Med Bras (1992) 2018;64:791-8. [PMID: 30672999 DOI: 10.1590/1806-9282.64.09.791] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Chapman WC, Korenblat KM, Fowler KJ, Saad N, Khan AS, Subramanian V, Doyle MBM, Dageforde LA, Tan B, Grierson P, Lin Y, Xu M, Brunt EM. Hepatocellular carcinoma: Where are we in 2018? Curr Probl Surg 2018;55:450-503. [PMID: 30526875 DOI: 10.1067/j.cpsurg.2018.10.002] [Reference Citation Analysis]
9 Glantzounis GK, Paliouras A, Stylianidi MC, Milionis H, Tzimas P, Roukos D, Pentheroudakis G, Felekouras E. The role of liver resection in the management of intermediate and advanced stage hepatocellular carcinoma. A systematic review. Eur J Surg Oncol. 2018;44:195-208. [PMID: 29258719 DOI: 10.1016/j.ejso.2017.11.022] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
10 Qadan M, Fong ZV, Delman AM, Gabr A, Salem R, Shah SA. Review of Use of Y90 as a Bridge to Liver Resection and Transplantation in Hepatocellular Carcinoma. J Gastrointest Surg 2021. [PMID: 34345997 DOI: 10.1007/s11605-021-05095-x] [Reference Citation Analysis]
11 Glantzounis GK, Karampa A, Peristeri D. Radiological simultaneous portohepatic vein embolization (RASPE) and major hepatectomy with hepatocellular carcinoma (HCC). Hepatobiliary Surg Nutr 2021;10:267-9. [PMID: 33898574 DOI: 10.21037/hbsn-20-865] [Reference Citation Analysis]
12 Park GC, Lee SG, Yoon YI, Sung KB, Ko GY, Gwon DI, Jung DH, Jung YK. Sequential transcatheter arterial chemoembolization and portal vein embolization before right hemihepatectomy in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2020;19:244-51. [PMID: 32414576 DOI: 10.1016/j.hbpd.2020.04.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Zhang CW, Dou CW, Zhang XL, Liu XQ, Huang DS, Hu ZM, Liu J. Simultaneous transcatheter arterial chemoembolization and portal vein embolization for patients with large hepatocellular carcinoma before major hepatectomy. World J Gastroenterol 2020; 26(30): 4489-4500 [PMID: 32874060 DOI: 10.3748/wjg.v26.i30.4489] [Cited by in CrossRef: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Sun HC, Zhu XD. Downstaging Conversion Therapy in Patients With Initially Unresectable Advanced Hepatocellular Carcinoma: An Overview. Front Oncol 2021;11:772195. [PMID: 34869008 DOI: 10.3389/fonc.2021.772195] [Reference Citation Analysis]
15 Kouzuki K, Umeda K, Saida S, Kato I, Hiramatsu H, Okamoto T, Ogawa E, Okajima H, Furuta A, Adachi S, Daifu T, Takita J. Successful right hepatic trisectionectomy following percutaneous transhepatic portal embolization in a pediatric patient with undifferentiated embryonal sarcoma of the liver. Pediatr Blood Cancer 2021;:e29369. [PMID: 34582116 DOI: 10.1002/pbc.29369] [Reference Citation Analysis]
16 Wang Z, Peng Y, Hu J, Wang X, Sun H, Sun J, Shi Y, Xiao Y, Ding Z, Yang X, Tang M, Tang Z, Wang J, Lau WY, Fan J, Zhou J. Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy for Unresectable Hepatitis B Virus-related Hepatocellular Carcinoma: A Single Center Study of 45 Patients. Ann Surg. 2018;. [PMID: 29995681 DOI: 10.1097/sla.0000000000002942] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
17 Manzini G, Henne-Bruns D, Porzsolt F, Kremer M. Is there a standard for surgical therapy of hepatocellular carcinoma in healthy and cirrhotic liver? BMJ Open Gastroenterol. 2017;4:e000129. [PMID: 28405349 DOI: 10.1136/bmjgast-2016-000129] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
18 Cheung TT, Kwok PC, Chan S, Cheung CC, Lee AS, Lee V, Cheng HC, Chia NH, Chong CCN, Lai TW, Law ALY, Luk MY, Tong CC, Yau TCC. Hong Kong Consensus Statements for the Management of Unresectable Hepatocellular Carcinoma. Liver Cancer 2018;7:40-54. [PMID: 29662832 DOI: 10.1159/000485984] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
19 Matthew Hawkins C, Towbin AJ, Roebuck DJ, Monroe EJ, Gill AE, Thakor AS, Towbin RB, Cahill AM, Lungren MP. Role of interventional radiology in managing pediatric liver tumors: Part 2: percutaneous interventions. Pediatr Radiol 2018;48:565-80. [DOI: 10.1007/s00247-018-4072-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
20 Zhang Z, Ouyang G, Wang P, Ren Y, Liu Y, Chen J, Zhang Y, Liu J, Li L. Safe standard remnant liver volume after hepatectomy in HCC patients in different stages of hepatic fibrosis. BMC Surg 2021;21:57. [PMID: 33485329 DOI: 10.1186/s12893-021-01065-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Madhusudhan KS, Sharma S, Srivastava DN. Percutaneous radiological interventions of the portal vein: a comprehensive review. Acta Radiol 2022;:2841851221080554. [PMID: 35187977 DOI: 10.1177/02841851221080554] [Reference Citation Analysis]
22 Cannella R, Tselikas L, Douane F, Cauchy F, Rautou P, Duran R, Ronot M. Imaging-guided interventions modulating portal venous flow: evidence and controversies. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100484] [Reference Citation Analysis]
23 Müller PC, Linecker M, Kirimker EO, Oberkofler CE, Clavien PA, Balci D, Petrowsky H. Induction of liver hypertrophy for extended liver surgery and partial liver transplantation: State of the art of parenchyma augmentation-assisted liver surgery. Langenbecks Arch Surg 2021. [PMID: 33740114 DOI: 10.1007/s00423-021-02148-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Wang Z, Peng Y, Sun Q, Qu X, Tang M, Dai Y, Tang Z, Lau WY, Fan J, Zhou J. Salvage transhepatic arterial embolization after failed stage I ALPPS in a patient with a huge HCC with chronic liver disease: A case report. Int J Surg Case Rep 2017;39:131-5. [PMID: 28841539 DOI: 10.1016/j.ijscr.2017.07.034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
25 Vouche M, Degrez T, Bouazza F, Delatte P, Galdon MG, Hendlisz A, Flamen P, Donckier V. Sequential tumor-directed and lobar radioembolization before major hepatectomy for hepatocellular carcinoma. World J Hepatol 2017; 9(36): 1372-1377 [PMID: 29359022 DOI: 10.4254/wjh.v9.i36.1372] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
26 Kannappan O, Keditsu K, Bhagat M, Shrimal A, Polnaya A, Kulkarni S, Qureshi SS. Portal Vein Embolization for Future Liver Remnant Enhancement and Combined Modality Treatment for the Management of Post-hepatic Resection Biliary Fistula in an 18-Month Old Child With Hepatoblastoma. Front Surg 2019;6:54. [PMID: 31608285 DOI: 10.3389/fsurg.2019.00054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
27 Fernandes ESM, Rodrigues PD, Álvares-da-Silva MR, Scaffaro LA, Farenzena M, Teixeira UF, Waechter FL. Treatment strategies for locally advanced hepatocellular carcinoma. Transl Gastroenterol Hepatol 2019;4:12. [PMID: 30976715 DOI: 10.21037/tgh.2019.01.02] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
28 Le N, Rivard DC, Rentea RM, Manalang M, Andrews W, Kane B, Hendrickson RJ. Right trisegmentectomy after portal vein embolization in a high-risk toddler with hepatoblastoma. Pediatr Surg Int 2018;34:573-8. [PMID: 29600326 DOI: 10.1007/s00383-018-4250-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
29 Azoulay D, Bhangui P, Pascal G, Salloum C, Andreani P, Ichai P, Saliba F, Lim C. The impact of expanded indications on short-term outcomes for resection of malignant tumours of the liver over a 30 year period. HPB (Oxford) 2017;19:638-48. [PMID: 28495439 DOI: 10.1016/j.hpb.2017.04.005] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
30 Shao Z, Liu X, Peng C, Wang L, Xu D. Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review. World J Surg Oncol 2021;19:293. [PMID: 34598689 DOI: 10.1186/s12957-021-02401-4] [Reference Citation Analysis]
31 Peristeri DV, Tepelenis K, Karampa A, Kapodistrias N, Goussia AC, Pappas-Gogos G, Glantzounis GK. Metronomic chemotherapy with cyclophosphamide for the treatment of advanced hepatocellular cancer: A case report. Ann Med Surg (Lond) 2021;72:103043. [PMID: 34868572 DOI: 10.1016/j.amsu.2021.103043] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Mehrabi A, Khajeh E, Ghamarnejad O, Nikdad M, Chang D, Büchler MW, Hoffmann K. Meta-analysis of the efficacy of preoperative biliary drainage in patients undergoing liver resection for perihilar cholangiocarcinoma. European Journal of Radiology 2020;125:108897. [DOI: 10.1016/j.ejrad.2020.108897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
33 Yoon YI, Lee SG, Moon DB, Hwang S, Kim KH, Kim HJ, Choi KH. Morbidity analysis of left hepatic trisectionectomy for hepatobiliary disease and live donor. Hepatobiliary Pancreat Dis Int 2022:S1499-3872(22)00128-X. [PMID: 35676187 DOI: 10.1016/j.hbpd.2022.05.010] [Reference Citation Analysis]
34 Papamichail M, Pizanias M, Heaton ND, M P, M P, Nd H. Minimizing the risk of small-for-size syndrome after liver surgery. Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00230-7. [PMID: 34961675 DOI: 10.1016/j.hbpd.2021.12.005] [Reference Citation Analysis]
35 Onishi Y, Isoda H, Ohno T, Shimizu H, Shimada K, Taura K, Hatano E, Nakamoto Y. Future liver remnant hypertrophy rate in portal vein embolization before left trisectionectomy: a retrospective cohort study. Abdom Radiol (NY) 2022;47:878-84. [PMID: 34958405 DOI: 10.1007/s00261-021-03387-z] [Reference Citation Analysis]
36 Nitta N, Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Ohgi K, Uesaka K. Differences in the safety line of the future liver remnant plasma clearance rate of indocyanine green necessary to prevent post-hepatectomy liver failure associated with underlying diseases. Surg Today 2021. [PMID: 34052906 DOI: 10.1007/s00595-021-02310-9] [Reference Citation Analysis]
37 Hu M, Hu H, Cai W, Mo Z, Xiang N, Yang J, Fang C. The Safety and Feasibility of Three-Dimensional Visualization Technology Assisted Right Posterior Lobe Allied with Part of V and VIII Sectionectomy for Right Hepatic Malignancy Therapy. J Laparoendosc Adv Surg Tech A. 2018;28:586-594. [PMID: 29172950 DOI: 10.1089/lap.2017.0479] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
38 Yoh T, Cauchy F, Kawai T, Schneck A, Le Roy B, Goumard C, Sepulveda A, Dokmak S, Farges O, Scatton O, Soubrane O. Laparoscopic right hepatectomy using the caudal approach is superior to open right hepatectomy with anterior approach and liver hanging maneuver: a comparison of short-term outcomes. Surg Endosc 2020;34:636-45. [DOI: 10.1007/s00464-019-06810-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
39 Madhusudhan KS, Vyas S, Sharma S, Srivastava DN, Gupta AK. Portal vein abnormalities: an imaging review. Clinical Imaging 2018;52:70-8. [DOI: 10.1016/j.clinimag.2018.07.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
40 Vaghiri S, Alaghmand Nejad S, Kasprowski L, Prassas D, Safi SA, Schimmöller L, Krieg A, Rehders A, Lehwald-Tywuschik N, Knoefel WT. A single center comparative retrospective study of in situ split plus portal vein ligation versus conventional two-stage hepatectomy for cholangiocellular carcinoma. Acta Chir Belg 2022;:1-12. [PMID: 35317718 DOI: 10.1080/00015458.2022.2056680] [Reference Citation Analysis]
41 Charalel RA, Sung J, Askin G, Jo J, Mitry M, Chung C, Tmanova L, Madoff DC. Systematic Reviews and Meta-Analyses of Portal Vein Embolization, Associated Liver Partition and Portal Vein Ligation, and Radiation Lobectomy Outcomes in Hepatocellular Carcinoma Patients. Curr Oncol Rep 2021;23:135. [PMID: 34716800 DOI: 10.1007/s11912-021-01075-1] [Reference Citation Analysis]
42 Rassam F, Roos E, van Lienden KP, van Hooft JE, Klümpen HJ, van Tienhoven G, Bennink RJ, Engelbrecht MR, Schoorlemmer A, Beuers UHW, Verheij J, Besselink MG, Busch OR, van Gulik TM. Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience. Langenbecks Arch Surg 2018;403:289-307. [PMID: 29350267 DOI: 10.1007/s00423-018-1649-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
43 Lidsky ME, Jarnagin WR. Surgical management of hilar cholangiocarcinoma at Memorial Sloan Kettering Cancer Center. Ann Gastroenterol Surg 2018;2:304-12. [PMID: 30003193 DOI: 10.1002/ags3.12181] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
44 López-López V, Robles-Campos R, Brusadin R, López-Conesa A, Navarro Á, Arevalo-Perez J, Gil PJ, Parrilla P. Tourniquet-ALPPS is a promising treatment for very large hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Oncotarget 2018;9:28267-80. [PMID: 29963276 DOI: 10.18632/oncotarget.25538] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
45 Kohno S, Isoda H, Ono A, Furuta A, Taura K, Shibata T, Togashi K. Portal Vein Embolization: Radiological Findings Predicting Future Liver Remnant Hypertrophy. AJR Am J Roentgenol 2020;214:687-93. [PMID: 31642696 DOI: 10.2214/AJR.19.21440] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Khayat S, Cassese G, Quenet F, Cassinotto C, Assenat E, Navarro F, Guiu B, Panaro F. Oncological Outcomes after Liver Venous Deprivation for Colorectal Liver Metastases: A Single Center Experience. Cancers (Basel) 2021;13:E200. [PMID: 33429913 DOI: 10.3390/cancers13020200] [Reference Citation Analysis]
47 Byrd K, Alqahtani S, Yopp AC, Singal AG. Role of Multidisciplinary Care in the Management of Hepatocellular Carcinoma. Semin Liver Dis 2021;41:1-8. [PMID: 33764480 DOI: 10.1055/s-0040-1719178] [Reference Citation Analysis]
48 Anderson B, Doyle MBM. Surgical Considerations of Hilar Cholangiocarcinoma. Surg Oncol Clin N Am 2019;28:601-17. [PMID: 31472908 DOI: 10.1016/j.soc.2019.06.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
49 Huang Y, Ge W, Kong Y, Ding Y, Gao B, Qian X, Wang W. Preoperative Portal Vein Embolization for Liver Resection: An updated meta-analysis. J Cancer 2021;12:1770-8. [PMID: 33613766 DOI: 10.7150/jca.50371] [Reference Citation Analysis]
50 Liu L, Li NF, Zhang Q, Lin L. Hepatocellular carcinoma successfully treated with ALPPS and apatinib: A case report. World J Clin Cases 2019; 7(16): 2384-2392 [PMID: 31531335 DOI: 10.12998/wjcc.v7.i16.2384] [Reference Citation Analysis]
51 Khan AS, Garcia-Aroz S, Ansari MA, Atiq SM, Senter-Zapata M, Fowler K, Doyle MB, Chapman WC. Assessment and optimization of liver volume before major hepatic resection: Current guidelines and a narrative review. Int J Surg. 2018;52:74-81. [PMID: 29425829 DOI: 10.1016/j.ijsu.2018.01.042] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 8.8] [Reference Citation Analysis]
52 Kishore SA, Bajwa R, Madoff DC. Embolotherapeutic Strategies for Hepatocellular Carcinoma: 2020 Update. Cancers (Basel) 2020;12:E791. [PMID: 32224882 DOI: 10.3390/cancers12040791] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
53 Peng C, Li C, Liu C, Wen T, Yang J, Li B, Yan L. The outcome of the HCC patients underwent ALPPS: Retrospective study. Medicine (Baltimore) 2019;98:e17182. [PMID: 31567959 DOI: 10.1097/MD.0000000000017182] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
54 Iida M, Yamamoto Y, Katoh H, Taniguchi N, Abe Y, Kumagai K, Uchinami H. 99mTc-GSA scintigraphy for assessing the functional volume ratio of the future liver remnant in the routine practice of liver resection. Surgery Open Science 2022. [DOI: 10.1016/j.sopen.2021.12.001] [Reference Citation Analysis]
55 Yang T, Whitlock RS, Vasudevan SA. Surgical Management of Hepatoblastoma and Recent Advances. Cancers (Basel) 2019;11:E1944. [PMID: 31817219 DOI: 10.3390/cancers11121944] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
56 Giuliante F, Ardito F, Aldrighetti L, Ferrero A, Pinna AD, De Carlis L, Cillo U, Jovine E, Portolani N, Gruttadauria S, Mazzaferro V, Massani M, Rosso E, Ettorre GM, Ratti F, Guglielmi A, Cescon M, Colasanti M, Di Sandro S, Gringeri E, Russolillo N, Ruzzenente A, Sposito C, Zanello M, Zimmitti G; Italian Association of HepatoBilioPancreatic Surgeons-AICEP., Italian Association of Hepato-Biliary-Pancreatic Surgeons-AICEP. Liver resection for perihilar cholangiocarcinoma: Impact of biliary drainage failure on postoperative outcome. Results of an Italian multicenter study. Surgery 2021;170:383-9. [PMID: 33622570 DOI: 10.1016/j.surg.2021.01.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Liang L, Quan B, Wu H, Diao YK, Li J, Chen TH, Zhang YM, Zhou YH, Zhang WG, Wang H, Serenari M, Cescon M, Schwartz M, Zeng YY, Liang YJ, Jia HD, Xing H, Li C, Wang MD, Yan WT, Chen WY, Lau WY, Zhang CW, Pawlik TM, Huang DS, Shen F, Yang T. Development and validation of an individualized prediction calculator of postoperative mortality within 6 months after surgical resection for hepatocellular carcinoma: an international multicenter study. Hepatol Int 2021;15:459-71. [PMID: 33534082 DOI: 10.1007/s12072-021-10140-7] [Reference Citation Analysis]
58 Xie DY, Ren ZG, Zhou J, Fan J, Gao Q. 2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights. Hepatobiliary Surg Nutr. 2020;9:452-463. [PMID: 32832496 DOI: 10.21037/hbsn-20-480] [Cited by in Crossref: 26] [Cited by in F6Publishing: 33] [Article Influence: 13.0] [Reference Citation Analysis]
59 Mukund A, Mondal A, Patidar Y, Kumar S. Safety and outcomes of pre-operative portal vein embolization using N-butyl cyanoacrylate (Glue) in hepatobiliary malignancies: A single center retrospective analysis. Indian J Radiol Imaging 2019;29:40-6. [PMID: 31000940 DOI: 10.4103/ijri.IJRI_454_18] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
60 Kimbrough CW, Cloyd JM, Pawlik TM. Surgical approaches for the treatment of perihilar cholangiocarcinoma. Expert Review of Anticancer Therapy 2018;18:673-83. [DOI: 10.1080/14737140.2018.1473039] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
61 Lauterio A, De Carlis R, Centonze L, Buscemi V, Incarbone N, Vella I, De Carlis L. Current Surgical Management of Peri-Hilar and Intra-Hepatic Cholangiocarcinoma. Cancers (Basel) 2021;13:3657. [PMID: 34359560 DOI: 10.3390/cancers13153657] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Gunasekaran G, Bekki Y, Lourdusamy V, Schwartz M. Surgical Treatments of Hepatobiliary Cancers. Hepatology 2021;73 Suppl 1:128-36. [PMID: 32438491 DOI: 10.1002/hep.31325] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 29.0] [Reference Citation Analysis]
63 Deng Z, Jin Z, Qin Y, Wei M, Wang J, Lu T, Zhang L, Zeng J, Bao L, Guo Y, Peng M, Xu B, Wen Z. Efficacy of the association liver partition and portal vein ligation for staged hepatectomy for the treatment of solitary huge hepatocellular carcinoma: a retrospective single-center study. World J Surg Oncol 2021;19:95. [PMID: 33785022 DOI: 10.1186/s12957-021-02199-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]